Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Regular hormone panels and metabolic checks (IGF-1, glucose, and lipid levels) are recommended every 36 months for long-term balance
Retatrutide is a next-generation research peptide being studied for its interaction with multiple metabolic receptor pathways, including GLP-1, GIP, and glucagon signaling systems
In the most recent Phase 3 trial, participants on the 12 mg dose lost an average of 28.7% of their body weight at 68 weeks
Referncias: 1- Literatura do Fornecedor
US$ 20.88
US$ 23.73
US$ 28.51
US$ 23.09
